Consumer health, the business of selling health and wellness sustaining-brands in categories as diverse as pain relievers,brain-boosting yogurts.
Michael Winter
Consumer health, the business of selling health and wellness sustaining-brands in categories as diverse as pain relievers, brain-boosting yogurts, sports nutrition, baby food and bone supplement drinks, is poised to take off globally.
With consumers becoming ever more health-aware and knowledgeable, companies from both the pharma and consumer segments are competing hard to get a piece of the action.
Which players will successfully harness the segment’s potential? Whatever the outcome of the battle, talent will be a critical weapon, as interviews with C-suite executives from top food, personal care and OTC drug companies have recently shown.
The war for talent between pharma and consumer players looks set to be intense, with both sides keen - and ever more active - to lure away senior talent from their competitors to plug competence gaps and boost their own executive bench strength. This is easier said than done. Finding, attracting, convincing, and integrating this talent can be tough. It takes courage and vision for companies to move away from familiar territory and recruit a new breed of leader.
Top consumer health leaders tend to display four exceptional competency spikes.
Finding executives who meet these criteria is an issue facing consumer health businesses. In some cases they may need to take a lateral view of the talent pool, perhaps even looking to other sectors to find high-calibre leaders with the right profile.
Recruiting this kind of leadership talent, however, is merely the first step. Effective onboarding is absolutely essential. This involves companies making a serious commitment to integrating new talent. Only those companies that are truly committed to consumer health, have a clear vision and are ready to make a serious investment will attract outstanding talent that transcends the respective legacies of the pharma and consumer industries.
Michael Winter is a consultant with executive search and advisory firm Egon Zehnder.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.